Search

everythinglearnresearchcommunity

for

Search:↓

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Topical corticosteroid treatment showed no significant difference from placebo in treating alopecia areata in children.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

Weight-loss drugs are not linked to suicidal thoughts.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

FK506 may stimulate hair growth when applied to the skin.

Cyclosporin A helps mice grow hair by blocking a specific protein activity in skin cells.

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Hair regrowth was achieved using 5-Fluorouracil and Bleomycin for scalp atrophy caused by corticosteroids.

A woman's rare adrenal tumor caused high testosterone and cortisol levels, which normalized after the tumor was removed.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

These new skin treatments are safer and more effective with minimal side effects.

Recreational drug use can cause misdiagnosed conditions and drug interactions in HIV patients.

Careful patient selection is key for effective pulse corticosteroid treatment in children with alopecia areata.

A patient produced cortisol after adrenalectomy, possibly due to residual tissue or other body parts making steroids.

Patients treated with long-term intralesional corticosteroids for alopecia areata should be monitored for bone density changes and advised on osteoporosis prevention.

Combining Cyclosporine A with low-dose corticosteroids effectively treats severe alopecia areata.

A pancreatic tumor caused high glucagon levels and symptoms, but treatment reduced glucagon and shrank liver tumors.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

Prednisolone can quickly regrow hair in alopecia universalis, but hair falls out after stopping it.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Somatostatin analogues effectively manage ectopic ACTH syndrome when surgery isn't possible.

Drugs that block GSK-3 show promise for treating various diseases.

Dexamethasone reduces inflammation and delays skin cell changes caused by TPA.

Topical corticosteroid was not more effective than placebo for children's alopecia areata, and atopy did not change treatment results.